Working to improve formulation of RNA-based pharmaceuticals

Nov 01, 2023 (Nanowerk News) A team of university and industry researchers is developing new formulations and manufacturing processes for the messenger RNA (mRNA) delivery systems used in some COVID vaccines. The mRNA-based vaccines that came out during the COVID-19 pandemic required storage at subzero temperatures. “They were shipped around the world as a piece of ice, a little frozen vial. That wasn’t ideal from a supply chain perspective, from a stability of goods perspective, from a storage perspective,” said Kurt Ristroph, assistant professor of agricultural…

Continue Reading


News Source: www.nanowerk.com


Posted

in

by

Tags: